CLINICAL_TRIALS
trial_result
· 2024-12-03
Clinical Trial Update: Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts [Phase 1]
Summary
Phase 1 study evaluating safety, tolerability, and PK of SZEY-2108 in healthy volunteers (SAD and MAD cohorts) has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Suzhou Erye Pharmaceutical Co., Ltd. | Conditions: Infections | Phase 1 | Status: TERMINATED